Explain how genetic technologies such as recombinant DNA, genetically modified organisms, cloning, gene editing and epigenetic tools work, evaluate their implications, interpret gel electrophoresis results, and place the key discoveries of genetics on a timeline

Learning goal: Describe current genetic engineering practices (recombinant DNA and specially modified bacteria, genetically modified organisms, cloning, CRISPR gene editing and epigenetic technology) and evaluate the implications of implementing them; propose and defend a solution to a real problem that uses genetic technology; explain how gel electrophoresis is used to evaluate DNA results in crime scene analysis, paternity testing and phylogenetic relationships; and create a timeline of the significant discoveries in genetics.

How the knowledge was built. The model of DNA that this course uses was not the work of one person or one experiment. Gregor Mendel published his pea experiments in 1866 and showed that traits pass in discrete units. Friedrich Miescher isolated a phosphorus-rich substance from cell nuclei in 1869 that we now call DNA. In 1928 Frederick Griffith showed that something from dead bacteria could transform living ones, and in 1944 Oswald Avery and colleagues showed that the something was DNA. Erwin Chargaff, who turned to DNA chemistry after Avery's result, measured the base composition of DNA from many species and established that A equals T and G equals C. Rosalind Franklin's X-ray diffraction images of DNA fibers, made in 1952, revealed a helix of regular dimensions, and in 1953 James Watson and Francis Crick, drawing on Franklin's data and Chargaff's rules, proposed the double helix with complementary base pairing. In 1958 Matthew Meselson and Franklin Stahl confirmed that replication is semi-conservative, and by 1966 Marshall Nirenberg and others had worked out which codon specifies which amino acid. From there the story turns technological: the first recombinant DNA molecules in 1972 and their cloning in bacteria in 1973, DNA sequencing in 1977, the polymerase chain reaction in 1983, the first cloned mammal from an adult cell in 1996, the Human Genome Project completed in 2003 and the CRISPR-Cas9 editing method described in 2012. Each step depended on experiments, hypotheses, statistics and new instruments, and on many scientists whose names are less often told.

Recombinant DNA and modified bacteria. Restriction enzymes cut DNA at specific short sequences, and DNA ligase joins pieces together. That pair of tools lets a gene from one organism (for a human gene, usually a copy without its non-coding stretches, which bacteria cannot remove) be inserted into a small circular DNA molecule, a plasmid, and the plasmid placed into bacteria, which then copy it and transcribe and translate the foreign gene. Human insulin produced this way was approved by the U.S. Food and Drug Administration in 1982, replacing insulin extracted from pig and cattle pancreases; the bacterial product is chemically identical to the human hormone. Bacteria and yeast now make vaccines, enzymes for detergents and cheese, and growth hormone. The general lesson is that the genetic code is universal enough that a human gene is read correctly by a bacterial ribosome.

Genetically modified organisms. A GMO is an organism whose genome has been altered by inserting, removing or editing genes rather than by breeding alone. Widely grown examples are corn and cotton carrying a bacterial gene for a protein toxic to certain insect larvae, and soybeans carrying a gene that makes them tolerant of a particular herbicide. Golden rice carries genes that let the grain make beta-carotene, which the body converts to vitamin A, intended for regions where vitamin A deficiency causes blindness and death in children. Evaluating any GMO means weighing measurable benefits (yield, reduced insecticide spraying, nutrition) against risks and costs: gene flow to wild relatives or neighboring crops, the evolution of resistant pests and weeds through natural selection, effects on non-target species, dependence on seed suppliers, and public trust. Scientific reviews to date have not found approved GM foods to be less safe to eat than conventional ones, but ecological and economic effects depend on the specific crop, gene and place, so a good evaluation is specific rather than general.

Cloning. Reproductive cloning of an animal transfers the nucleus of a body cell into an egg whose own nucleus has been removed; the egg develops into an animal genetically nearly identical to the donor. The first mammal cloned from an adult cell was a sheep born in 1996. Cloning is inefficient, many embryos fail, and it copies a genome, not an individual: a clone raised in a different environment develops differently. Bacteria and plants clone themselves naturally, and cuttings and grafts are cloning by another name.

Gene editing with CRISPR. CRISPR-Cas9 is an adapted bacterial defense system. A guide RNA is designed to match a chosen 20-base sequence in the genome; it leads the Cas9 protein to that site, where Cas9 cuts both DNA strands. The cell's repair machinery then either seals the break imperfectly, which usually disables the gene, or, if a template is supplied, copies in a designed change. The method is far cheaper and more precise than earlier tools, and the first medical treatment based on it, for sickle cell disease and a related blood disorder, was approved in the United Kingdom on 16 November 2023 for both conditions and in the United States on 8 December 2023 for sickle cell disease and on 16 January 2024 for the related disorder, beta-thalassemia; it edits a patient's own blood-forming cells outside the body. Concerns include edits at unintended sites, edits to embryos that would be inherited by future generations, which most scientific bodies currently oppose, cost and access.

Epigenetic technology. Epigenetics concerns changes in gene activity that do not change the DNA sequence, such as the attachment of methyl groups to DNA or chemical tags on the proteins DNA wraps around, which switch genes on or off and can persist through cell division. Some drugs act by altering these tags, for instance in certain cancers, and editing tools now exist that place or remove tags at chosen genes without cutting the DNA. Because such changes can sometimes be reversed, they are an attractive route for therapies, and because some can be influenced by environment and diet, they connect heredity to lifestyle in ways still being studied.

Gel electrophoresis, worked in the prose. DNA fragments carry a negative charge because of their phosphate groups. In gel electrophoresis, samples are loaded into wells at one end of a slab of gel and an electric field is applied; the fragments move toward the positive electrode, and because the gel is a mesh, smaller fragments slip through faster and travel farther than larger ones in the same time. A ladder of fragments of known size run alongside lets the size of an unknown band be read. Suppose a ladder gives bands at 10 mm for 1,000 base pairs, 25 mm for 500 base pairs and 40 mm for 250 base pairs, and an unknown fragment sits at 25 mm; it is about 500 base pairs long. The pattern of bands is a DNA profile. In crime scene analysis, the profile of DNA from evidence is compared with a suspect's; matching bands at many variable positions are strong evidence of a common source, and in this simplified, error-free picture a single mismatch excludes. In paternity testing, every band in a child's profile must come from the mother or the father; a band present in neither excludes the alleged father, again in the simplified picture (real laboratories allow for rare mutations and technical error before excluding anyone). In phylogenetics, comparing the fragment patterns or sequences of several species measures their similarity, from which relatedness is inferred. Electrophoresis does not read the sequence; it sorts by size.

Proposing a solution with genetic technology. Ohio's course asks students to take a real problem and propose a solution using genetic technology and defend the reasoning. A proposal needs the problem, the organism and gene to be changed, the technique, the expected benefit, the risks and how they would be monitored, and the alternatives that were rejected. For example, to protect a region's staple crop from a fungal disease: identify a resistance gene in a wild relative, transfer it by editing or recombinant methods, field-test for yield and for effects on neighboring plants, keep unmodified seed available, and compare with the alternative of conventional breeding, which is slower but avoids regulatory and acceptance hurdles.

Misconceptions. "A GMO contains genes and a normal plant does not" is nonsense; every organism has genes, and what differs is how they were changed. "Electrophoresis reads the DNA sequence" is wrong; it separates fragments by size. "Cloning makes an identical person or animal" overstates; it copies a genome, and development and experience differ. "Gene editing is exact and final" ignores off-target cuts and repair errors.

Investigation you can do. Run a real electrophoresis with food dyes: dissolve 1 g of agar or agarose in 100 mL of a dilute baking-soda solution, pour into a shallow dish with a comb to form wells, and have the teacher assemble the electrical part: two 9-volt batteries in series connected by clip leads to stainless-steel or graphite electrodes at either end (an adult pours the hot agar; the leads must never touch each other, and the batteries are disconnected before anyone touches the gel or electrodes), and load drops of different food colorings mixed with glycerin. Watch the dyes separate into bands over 20 to 30 minutes, measure how far each travels and record which move toward which electrode. A result in which a mixed sample separates into the same bands as the single dyes supports the claim that electrophoresis separates a mixture into components by charge and size. What the model cannot show: food dyes are not DNA, they differ in charge as well as size and some move toward the negative electrode, so the model cannot show that DNA fragments all move one way and separate by size alone; it also cannot show how a profile is compared statistically.

Worked paternity gel: A child's profile shows bands at 300 and 500 base pairs. The mother's shows 300 and 700; the alleged father's shows 500 and 900. The child's 300 band came from the mother; the 500 band is not in the mother and is in the alleged father, so he is not excluded. At a second marker the child shows 150 and 220; the mother shows 150 and 180; the alleged father shows 260 and 310. The 220 band is in neither parent, so the alleged father is excluded, unless a mutation occurred, which is rare. In this simplified, error-free model one exclusion outweighs any number of consistent markers; real laboratories, allowing for mutation and technical error, usually require exclusions at more than one marker before excluding a man. Consistency at many markers builds a probability of paternity but never a proof.

Worked crime scene comparison: DNA from a stain is compared with samples from two suspects across five variable markers. Suspect 1 matches at all five; suspect 2 mismatches at the second marker. Suspect 2 is excluded as the source. For suspect 1, the strength of the match depends on how common each matching allele is; if each of the five matching patterns is found in 1 in 10 people and the markers are independent, the chance that a random unrelated person matches all five is 1 in 100,000, so the match is strong evidence but not certainty, and the argument must state the population frequencies it used.

Worked size estimate from a ladder: A ladder gives bands at 10 mm (1,000 base pairs), 25 mm (500) and 40 mm (250). Each halving of size adds 15 mm of travel, so distance is proportional to the logarithm of size for this gel. An unknown at 32.5 mm lies halfway between the 500 and 250 marks in distance, so its size is about halfway on the logarithmic scale, roughly 350 base pairs. The estimate is approximate because the relationship is only roughly logarithmic and the bands have width.

Worked proposal and defense: Problem: a coastal town has an oil spill in a marsh. Proposal using genetic technology: use recombinant DNA to give a harmless soil bacterium extra copies of the genes for the enzymes that break down hydrocarbons, and add a built-in genetic dependency on a nutrient not found in the marsh so that the strain cannot survive once treatment stops; test it first in sealed tanks of marsh mud, then in small fenced plots, monitoring oil concentration, oxygen and whether the strain persists. Defense: the bacteria use the hydrocarbons as food and convert them to carbon dioxide and water, and the extra enzyme copies could speed that; the dependency and staged testing address the risk of an engineered organism spreading. Comparison with a non-genetic alternative: adding nutrients to the naturally occurring oil-degrading bacteria already at the site is slower but raises fewer release and ecological questions, so the proposal would be withdrawn if the engineered strain did not clearly outperform it in the tank tests or if it persisted after treatment.

Supported record: Draw a timeline from 1860 to the present with at least ten labeled discoveries in genetics, each with the year, the person or team and a phrase saying what was learned or made possible. Beside it, sketch a gel with a ladder lane and three sample lanes for the paternity example, labeling the positive and negative electrodes and the direction of DNA movement.

Independent performance: Choose one current world problem from disease, hunger, pests or water quality and write a proposal for a solution that uses genetic technology. Success criteria: (a) the problem is stated with its cause; (b) the organism, gene and technique (specially modified bacteria, GMO, CRISPR editing or epigenetic technology) are named and the mechanism is explained in your own words; (c) the expected benefit is stated and one way to measure it is given; (d) at least two risks or implications (ecological, health, economic or ethical) are named with a plan to monitor or limit each; (e) one alternative not using genetic technology is compared honestly; (f) the reasoning is defended in a closing paragraph that says what evidence would make you withdraw the proposal.